Tuesday, May 24, 2016

Novo Nordisk T2D Combo Wins FDA Panel Support

(MedPage Today) -- Concerns about insulin degludec-liraglutide combo didn't trump overall efficacy
via Novo Nordisk T2D Combo Wins FDA Panel Support
by
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)